These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2951055)

  • 1. [Buflomedil chlorhydrate in peripheral vasculopathies].
    Dall'Antonia F; Perbellini A; Adami CA; Dal Cortivo G; Bucci S
    Clin Ter; 1986 Dec; 119(5):379-85. PubMed ID: 2951055
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs].
    Coglitore S; Manganaro A; Barbera MC; Cento D; Buda D; Arrigo F; Consolo F
    Minerva Cardioangiol; 1986 Nov; 34(11):745-9. PubMed ID: 2949163
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].
    Lucisano V; Margheriti R; Matone P; Morrieri C; Rugolo A; Corsi V
    Clin Ter; 1986 Jun; 117(6):499-509. PubMed ID: 3527536
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience with buflomedil in peripheral arterial occlusive disease.
    Balas P; Pagratis N
    Angiology; 1981 Oct; 32(10):679-85. PubMed ID: 7325404
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].
    Sunder-Plassmann L; Gandolfo AM; Utz C
    MMW Munch Med Wochenschr; 1984 Mar; 126(9):247-8. PubMed ID: 6425678
    [No Abstract]   [Full Text] [Related]  

  • 6. [Buflomedil in arterial occlusive disease. Results of a controlled study].
    Trübestein G; Balzer K; Bisler H; Klüken N; Mahfoud Y; Müller-Wiefel H; Unkel B; Ziegler W
    Dtsch Med Wochenschr; 1982 Dec; 107(51-52):1957-61. PubMed ID: 6756854
    [No Abstract]   [Full Text] [Related]  

  • 7. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy].
    Abate S; Ferulano GP; Vanni L; Dilillo S; Picilli M; D'Alessio E
    Minerva Cardioangiol; 1985 Nov; 33(11):749-56. PubMed ID: 2935748
    [No Abstract]   [Full Text] [Related]  

  • 8. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
    Frausini G; Rotatori P; Gaggi S; Barone A; Pupita F
    Minerva Cardioangiol; 1988 Jun; 36(6):319-22. PubMed ID: 3211330
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study].
    Andreozzi GM; Lepore R
    Clin Ter; 1990 Nov; 135(4):273-81. PubMed ID: 2150026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G; Balzer K; Bisler H; Klüken N; Muller-Wiefel H; Unkel B; Mahfoud Y; Ziegler W
    Angiology; 1984 Aug; 35(8):500-5. PubMed ID: 6383127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute affect of buflomedil hydrochloride (bufedil) on transcutaneously measured oxygen pressures in patients with peripheral arterial occlusive disease].
    Lemke R; Klaus D
    Vasa; 1984; 13(2):171-4. PubMed ID: 6741240
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V; Mammarella A; Alessandrini A; Barlattani M
    Clin Ter; 1984 Jul; 110(1):29-36. PubMed ID: 6237843
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of buflomedil on peripheral arteriopathies. An open clinical study].
    Longo FN; Potortì F; Urbano O; Perroni GB
    Minerva Cardioangiol; 1988 May; 36(5):249-52. PubMed ID: 3059229
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation.
    Mozzi E; Chiurazzi D; Spinola A; Annoni F; Germiniani R
    J Int Med Res; 1985; 13(6):317-21. PubMed ID: 4076530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multicenter study on the therapeutic activity of buflomedil chlorhydrate in obliterative arteriopathies of the legs].
    Allegra C; Andreozzi GM; Avellone G; Cospite M; Del Guercio R; Lepore R; Nuzzaci G; Pinto A; Romeo S
    Clin Ter; 1986 Oct; 119(1):25-33. PubMed ID: 3539466
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of buflomedil hydrochloride in occlusive arterial disease of the lower limbs stage IV.
    Briguglio F; Briguglio E; Di Marco V; Swat M; Materia G; Intilisano A
    J Int Med Res; 1986; 14(3):115-23. PubMed ID: 3721052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of buflomedil chlorhydrate on local oxygen delivery in peripheral vascular disease.
    Mannarino E; Pasqualini L; Maragoni G; Orlandi U
    Angiology; 1989 Jun; 40(6):559-62. PubMed ID: 2719340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
    Racenberg J; Intaglietta M; Messmer K
    Fortschr Med; 1982 Nov; 100(41):1926-30. PubMed ID: 7152426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies].
    Tallarida G; Baldoni F; Peruzzi G; Raimondi G; Grimaldi I; Visigalli G; Gristina S; Massaro M; De Martinis L; Sangiorgi M
    Cardiologia; 1983 Aug; 28(8):651-60. PubMed ID: 6687209
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bencyclane in stage II arterial occlusive disease. Results of a controlled study].
    Trübestein G; Trübestein R; Ludwig M
    Fortschr Med; 1989 Dec; 107(36):781-4. PubMed ID: 2695437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.